scholarly journals Investigation of the efficacy of generic and brand-name tiotropium bromide in the management of chronic obstructive pulmonary disease: A randomized comparative trial

2016 ◽  
Vol 24 (2) ◽  
pp. 147-152 ◽  
Author(s):  
Yunes Panahi ◽  
Mostafa Ghanei ◽  
Mohammad Behzadi ◽  
Maryam Salehi ◽  
Sara Saffar Soflaei ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Comparative Trial ◽  
Tiotropium Bromide ◽  
Chronic Obstructive ◽  
Brand Name ◽  
Obstructive Pulmonary Disease

New Treatment for Chronic Obstructive Pulmonary Disease: Tiotropium Bromide

2005 ◽  
Vol 21 (3) ◽  
pp. 144-149
Author(s):  
Emily W Evans
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Clinical Outcomes ◽  
Data Extraction ◽  
Tiotropium Bromide ◽  
Chronic Obstructive ◽  
Duration Of Action ◽  
Obstructive Pulmonary Disease ◽  
Study Selection ◽  
New Treatment

Objective: To review chronic obstructive pulmonary disease (COPD) and evaluate the role of tiotropium bromide in its treatment. Data Sources: MEDLINE was searched for articles published between 1990 and June 2004 that contained the terms tiotropium and chronic obstructive pulmonary disease. Study Selection/Data Extraction: Selected studies documented clinical outcomes related to the use of tiotropium bromide and included a complete description of methods and results. These studies were examined to determine the extent of the effect of tiotropium on clinical outcomes involved in COPD. Data Synthesis: Tiotropium bromide has a long duration of action and thus can be dosed just once daily. It was found to improve lung function, reduce symptoms, improve health status, and decrease exacerbations compared with both placebo and other bronchodilator medications. Conclusions: Tiotropium appears to be a valuable addition to the current therapies available for COPD.

Sign in / Sign up

Export Citation Format

Share Document